Hepatocyte growth factor induces delayed STAT3 phosphorylation through interleukin-6 expression

被引:5
|
作者
Lee, Bok-Soon [1 ,2 ]
Park, Minseon [1 ]
Cha, Hyun-Young [1 ]
Lee, Jae-Ho [1 ,2 ]
机构
[1] Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea
[2] Ajou Univ, Dept Mol Sci & Technol, Grad Sch, Suwon 443721, South Korea
关键词
HGF/SF; STAT3; Met; Interleukin-6; PI3K; NF-KAPPA-B; RECEPTOR TYROSINE KINASE; MET RECEPTOR; SCATTER-FACTOR; TRANSCRIPTION FACTORS; MOLECULAR TARGETS; CARCINOMA-CELLS; IL-6; SECRETION; ACTIVATION; PROTEIN;
D O I
10.1016/j.cellsig.2008.11.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Met receptor tyrosine kinase mediates pleiotropic cellular responses following its activation by hepatocyte growth factor or scatter factor (HGF/SF), STAT3 was reported to be one of direct downstream molecules in HGF/SF-Met signaling. In the present study, however, we observed that Tyr705 of STAT3 was phosphorylated from 2 h or 6 h in NIH3T3 and Chang liver cells, respectively, after HGF/SF treatment. Blocking of the phosphorylation by cycloheximide or actinomycin D and the rapid STAT3 phosphorylation with the conditioned medium from HGF/SF-treated NIH3T3 cells suggested that a newly synthesized secretory protein was responsible for the delayed STAT3 phosphorylation. Among the known mediators to induce STAT3 phosphorylation, interleukin-6 (IL-6) mRNA and protein were induced by HGF/SF, and the released IL-6 was accumulated in the conditioned medium after HGF/SF treatment. Furthermore, the neutralizing IL-6 antibody abolished the STAT3 phosphorylation. Treatment with LY294002, a PI3 kinase inhibitor, but not with other signal inhibitors, resulted in the loss of delayed STAT3 phosphorylation by HGF/SF, showing the involvement of PI3 kinase pathway. Collectively, these results demonstrate that HGF/SF-Met signal cascade stimulates IL-6 production via PI3 kinase pathway, leading to STAT3 phosphorylation as a secondary effect. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:419 / 427
页数:9
相关论文
共 50 条
  • [41] Delta-4 expression on a stromal cell line is augmented by interleukin-6 via STAT3 activation
    Suzuki, Motoyuki
    Yamamoto, Mayuko
    Sugimoto, Akira
    Nakamura, Shuji
    Motoda, Ryuichi
    Orita, Kunzo
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 1143 - 1150
  • [42] Heteroarylketones inhibit astroglial interleukin-6 expression via a STAT3/NF-κB signaling pathway
    Ingo Schulz
    Claudia Engel
    André J Niestroj
    Ulrike Zeitschel
    Katja Menge
    Astrid Kehlen
    Antje Meyer
    Steffen Roßner
    Hans-Ulrich Demuth
    Journal of Neuroinflammation, 8
  • [43] Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
    Wei, LH
    Kuo, ML
    Chen, CA
    Chou, CH
    Lai, KB
    Lee, CN
    Hsieh, CY
    ONCOGENE, 2003, 22 (10) : 1517 - 1527
  • [44] Hepatocyte growth factor (HGF) regulates interleukin-6 (IL-6) production by macrophages
    Mars, WM
    Spardy, N
    Tse, H
    Milton, M
    Profozich, J
    Lavalley, ME
    Afrazi, A
    Piganelli, JD
    FASEB JOURNAL, 2005, 19 (04): : A479 - A479
  • [45] Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
    Lin-Hung Wei
    Min-Liang Kuo
    Chi-An Chen
    Chia-Hung Chou
    Kuo-Bau Lai
    Chien-Nan Lee
    Chang-Yao Hsieh
    Oncogene, 2003, 22 : 1517 - 1527
  • [46] CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer
    Zhang, Chunyan
    Xin, Hong
    Zhang, Wang
    Yazaki, Paul J.
    Zhang, Zhifang
    Le, Keith
    Li, Wenzhao
    Lee, Heehyoung
    Kwak, Larry
    Forman, Stephen
    Jove, Richard
    Yu, Hua
    IMMUNITY, 2016, 44 (04) : 913 - 923
  • [47] Interleukin-6 induces ErbBs receptor phosphorylation and utrophin expression in dystrophic myotubes.
    Juretic, Nevenka
    Diaz, Josefina
    Jaimovich, Enrique
    Riveros, Nora
    FASEB JOURNAL, 2013, 27
  • [48] Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity
    Thyrell, Lena
    Arulampalam, Velmurugesan
    Hjortsberg, Linn
    Farnebo, Marianne
    Grander, Dan
    Tamm, Katja Pokrouskaja
    EXPERIMENTAL CELL RESEARCH, 2007, 313 (19) : 4015 - 4024
  • [49] Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
    Griesinger, Andrea M.
    Josephson, Rebecca J.
    Donson, Andrew M.
    Levy, Jean M. Mulcahy
    Amani, Vladimir
    Birks, Diane K.
    Hoffman, Lindsey M.
    Furtek, Steffanie L.
    Reigan, Phillip
    Handler, Michael H.
    Vibhakar, Rajeev
    Foreman, Nicholas K.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10) : 1165 - 1174
  • [50] Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
    Kitamura, Hidemitsu
    Ohno, Yosuke
    Toyoshima, Yujiro
    Ohtake, Junya
    Homma, Shigenori
    Kawamura, Hideki
    Takahashi, Norihiko
    Taketomi, Akinobu
    CANCER SCIENCE, 2017, 108 (10): : 1947 - 1952